Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Epinephrine HFA-MDI (E004) in Healthy Volunteers
NCT01143051Phase 2Completed
- Start
- Jan 2010
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of epinephrine in asthma (3 arms). Primary endpoints: Baseline Concentration of Labeled Epinephrine Total Epinephrine, Area Under the Curve From Time Zero to 6 Hours Post-dose and 4 more. Started Jan 2010; status: completed.
02
Drugs
epinephrine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01143051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143051.